Search Results 401-410 of 9060 for Endemic
Contact the eMERGE Genome Informed Risk Assessment study coordinators at Mayo Clinic or Mountain Park Health Center.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The objective of this study is to assess the safety and tolerability, including the maximum tolerated dose, of ASP2215 in subjects with relapsed or treatment- ...
1 Diabetes (T1D). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
About this study. The purpsoe of this study is to identify the needs of LGBTQ+ individuals with IBD through a community-based participatory research and ...
The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...
About this study. The purpose of this study is to develop algorithms that will enable earlier identification and testing triggers for COVID-19 in otherwise ...
The purpose of this study is to define a comprehensive digital phenotype through radio signal-enabled passive environment monitoring, associated with clinical ...
The purpose of this study is to test safety and anti-tumor activity of BT062 in combination with lenalidomide and dexamethasone to define the best doses for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.